Background: Treatment-resistant depression (TRD) poses a substantial burden to health
care payers including employers, costing an estimated $29 billion-$48 billion yearly in the …

Purpose Second-generation long-acting injectable therapies (SGA-LAIs) may reduce health
care resource utilization (HRU) and health care costs compared with daily oral atypical …

Background Poor antipsychotic (AP) adherence is a key issue in patients with schizophrenia.
First-generation antipsychotic (FGA) and second-generation antipsychotic (SGA) long-…

Background Once-monthly paliperidone palmitate (PP1M) is a long-acting injectable antipsychotic
that may increase adherence rates, reduce hospitalizations, and lower medical costs …

Importance Although New York State (NYS) recently adopted legislation eliminating nonmedical
vaccination exemption options from school-entry requirements, the implications of the …

Background Rates of hospitalization due to chronic hepatitis C virus (HCV) are increasing in
Canada and the United States. A large proportion of immigrants originate from countries …

Importance: Following the repeal of nonmedical vaccine exemption options from school
entry immunization laws in California, gains in vaccine coverage were partially offset by …

The erythropoietin‐producing hepatocellular carcinoma receptor B4 is a receptor tyrosine
kinase whose expression is preserved in various malignancies, including colon, gastric, and …

Aim: Compare medication utilization, costs and healthcare resource use in schizophrenia
patients with substance-related disorders initiated on once-monthly paliperidone palmitate (…

This thesis is comprised of three projects that are driven by a common theme, which is the
use of computational tools in aiding molecular probe and drug design. In the first project, the …